デフォルト表紙
市場調査レポート
商品コード
914064

生殖補助医療(ART)の世界市場:規模、シェア、見通し、機会分析

Assistive Reproductive Technology Market, by Product Type, by Technology; by Procedure; by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis 2019 - 2027

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 170 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
生殖補助医療(ART)の世界市場:規模、シェア、見通し、機会分析
出版日: 2019年09月27日
発行: Coherent Market Insights
ページ情報: 英文 170 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートは世界の生殖補助医療(ART)市場について調査しており、市場機会や動向、成長および阻害要因、製品タイプ・技術・手順・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 調査の目的および前提条件

    • 調査目的
    • 前提条件
    • 略語

第2章 市場の範囲

    • レポートの説明
    • 市場の定義および範囲
    • エグゼクティブサマリー
    • 製品タイプ別
    • 技術別
    • 手順別
    • エンドユーザー別
    • 地域別
    • Coherent Opportunity Map (COM)

第3章 市場力学、規制、動向分析

    • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会
    • 影響分析
    • 新規製品の発売/承認
    • 買収・提携
    • 技術の進歩
    • 規制シナリオ
    • 償還シナリオ
    • 製品リコール
    • PEST分析
    • ポーターのファイブフォース分析
    • 疫学

第4章 市場分析:製品タイプ別

  • イントロダクション
  • 市場シェア分析
  • 前年比成長分析
  • セグメントの動向
  • 消耗品
  • 機器
    • イントロダクション
    • 市場規模・予測、前年比成長率
    • セグメントの動向

第5章 市場分析:技術別

  • イントロダクション
  • 市場シェア分析
  • 前年比成長分析
  • セグメントの動向
  • 体外受精(IVF)
  • 細胞質内精子注入(ICSI)を伴うIVF
  • 細胞質内精子注入なしのIVF(ICSI)
  • 人工授精・子宮内授精(AI-IUI)
  • 凍結胚の交換(FER)
  • その他
    • イントロダクション
    • 市場規模・予測、前年比成長率

第6章 市場分析:手順別

  • イントロダクション
  • 市場シェア分析
  • 前年比成長分析
  • セグメントの動向
  • 非凍結・ドナー
  • 凍結・ドナー
  • 非凍結・非ドナー
  • 胚/卵子バンク
  • その他
    • イントロダクション
    • 市場規模・予測、前年比成長率

第7章 市場分析:エンドユーザー別

  • イントロダクション
  • 市場シェア分析
  • 前年比成長分析
  • セグメントの動向
  • 不妊治療クリニック
  • IVFセンター
  • 病院
    • イントロダクション
    • 市場規模・予測、前年比成長率

第8章 市場分析:地域別

  • イントロダクション
  • 市場シェア分析
  • 前年比成長分析
  • 北米
    • 製品タイプ別
    • 技術別
    • 手順別
    • エンドユーザー別
    • 地域別
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • フランス
    • スペイン
    • ロシア
    • その他
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • ASEAN
    • オーストラリア
    • 韓国
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他
  • アフリカ
    • 中央アフリカ
    • 南アフリカ
    • 北アフリカ
  • 中東
    • GCC諸国
    • イスラエル
    • その他

第9章 競合情勢

  • ヒートマップ分析
  • 企業概要
  • Cooper Surgical Inc.
  • Hamilton Thorne, Inc.
  • FUJIFILM Irvine Scientific, Inc. (富士フイルム株式会社)
  • Nidacon International AB
  • Vitrolife AB
  • EMD Serono, Inc.
  • INVO Bioscience
  • IVFtech ApS
  • Gonagen Medikal
  • Cook Medical LLC.
  • CellCura ASA
  • Merck KGaA
    • 企業概要
    • 製品ポートフォリオ
    • 主な開発
    • 財務実績
    • 戦略

第10章 セクション

    • 参照資料
    • 調査方法
    • 当社について
目次

Assistive reproductive technology (ART) is an infertility treatment procedure. In this procedure, the sperm and eggs are taken out of the body and oocyte fertilization is done under laboratory environment. The fertilization process carried outside the body is known as In vitro fertilization (IVF). There are mainly two type of IVF procedures such IVF with Intracytoplasmic Sperm Injection (ICSI) and IVF without Intracytoplasmic Sperm Injection (ICSI).

Market Dynamics

Increase in infertility rates over the past years has supported growth of global assistive reproductive technologies market growth. For instance, according to the European society of Human Reproduction and Embryology (ESHRE) in 2018, more than 8 million babies, were born from IVF procedure. This rising number of IVF procedures is expected to boost the global assistive reproductive technology market growth.

Rising prevalence of infertility cases has led to an increase in demand for ART treatment techniques. Furthermore, higher rate of successful pregnancies and births resulting from ART cycles using fresh nondonor eggs or embryos is expected to facilitate the market growth. For instance, in 2016, as per IVF birth rate statistics, around 6.5 million babies were born using in-vitro fertilization (IVF). Moreover, according to the Centers for Disease Control and Prevention (CDC), around 1.6 percent of babies born in the United States each year are conceived through assisted reproductive technology (ART).

ART cycles, are carried out using various procedures such as fresh donor, frozen donor, fresh nondonor, frozen nondonor and embryo/egg banking. The choice of procedures also affects growth of the assistive reproductive technology market, depending upon the type of technology procedures are also chosen. In 2015, according to Centers for Disease Control and Prevention (CDC) 26% fresh nondonor and 42% frozen nondonor procedures were performed in the U.S. These factors are expected to propel the global assistive reproductive technology market growth.

Restraints of the Global Assistive Reproductive Technology Market

One of the major restraints of this market is the issue of legal parental rights, and few concern of people such as, whose names will be there on birth certificate and who will have parental responsibility. Such factors may refrain parents to make use of assistive reproductive technologies.

Key features of the study:

  • This report provides in-depth analysis of the global assistive reproductive technology market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global assistive reproductive technology market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Cooper Surgical Inc., Hamilton Thorne, Inc., FUJIFILM Irvine Scientific, Inc., Merck KGaA, Nidacon International AB, Vitrolife AB, EMD Serono, Inc., INVO Bioscience, IVFtech ApS, Gonagen Medikal, Cook Medical Llc., and CellCura ASA
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global assistive reproductive technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the assistive reproductive technology market.

Detailed Segmentation

  • Global Assistive Reproductive Technology Market, By Product Type:
  • Consumables
  • Instruments
  • Global Assistive Reproductive Technology Market, By Technology:
  • In-vitro fertilization (IVF)
    • IVF with Intracytoplasmic Sperm Injection (ICSI)
    • IVF without Intracytoplasmic Sperm Injection (ICSI)
  • Artificial Insemination-Intrauterine Insemination (AI-IUI)
  • Frozen Embryo Replacement (FER)
  • Others
  • Global Assistive Reproductive Technology Market, By Procedure:
  • Fresh Donor
  • Frozen Donor
  • Fresh Nondonor
  • Frozen Nondonor
  • Embryo/Egg Banking
  • Others
  • Global Assistive Reproductive Technology Market, By End User:
  • Fertility Clinics
  • IVF Center
  • Hospital
  • Global Assistive Reproductive Technology Market, By Region:
  • North America
    • By Product Type :
    • Consumables
    • Instruments
    • By Technology:
    • In-vitro fertilization (IVF)
    • IVF with Intracytoplasmic Sperm Injection (ICSI)
    • IVF without Intracytoplasmic Sperm Injection (ICSI)
    • Artificial Insemination-Intrauterine Insemination (AI-IUI)
    • Frozen Embryo Replacement (FER)
    • Others
    • By Procedure :
    • Fresh Donor
    • Frozen Donor
    • Fresh Nondonor
    • Frozen Nondonor
    • Embryo/Egg Banking
    • Others
    • By End User:
    • Fertility Clinics
    • IVF Center
    • Hospital
    • By Country:
    • U.S.
    • Canada
  • Europe
    • By Product Type :
    • Consumables
    • Instruments
    • By Technology:
    • In-vitro fertilization (IVF)
    • IVF with Intracytoplasmic Sperm Injection (ICSI)
    • IVF without Intracytoplasmic Sperm Injection (ICSI)
    • Artificial Insemination-Intrauterine Insemination (AI-IUI)
    • Frozen Embryo Replacement (FER)
    • Others
    • By Procedure :
    • Fresh Donor
    • Frozen Donor
    • Fresh Nondonor
    • Frozen Nondonor
    • Embryo/Egg Banking
    • Others
    • By End User:
    • Fertility Clinics
    • IVF Center
    • Hospital
    • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Product Type :
    • Consumables
    • Instruments
    • By Technology:
    • In-vitro fertilization (IVF)
    • IVF with Intracytoplasmic Sperm Injection (ICSI)
    • IVF without Intracytoplasmic Sperm Injection (ICSI)
    • Artificial Insemination-Intrauterine Insemination (AI-IUI)
    • Frozen Embryo Replacement (FER)
    • Others
    • By Procedure :
    • Fresh Donor
    • Frozen Donor
    • Fresh Nondonor
    • Frozen Nondonor
    • Embryo/Egg Banking
    • Others
    • By End User:
    • Fertility Clinics
    • IVF Center
    • Hospital
    • By Country:
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • By Product Type :
    • Consumables
    • Instruments
    • By Technology:
    • In-vitro fertilization (IVF)
    • IVF with Intracytoplasmic Sperm Injection (ICSI)
    • IVF without Intracytoplasmic Sperm Injection (ICSI)
    • Artificial Insemination-Intrauterine Insemination (AI-IUI)
    • Frozen Embryo Replacement (FER)
    • Others
    • By Procedure :
    • Fresh Donor
    • Frozen Donor
    • Fresh Nondonor
    • Frozen Nondonor
    • Embryo/Egg Banking
    • Others
    • By End User:
    • Fertility Clinics
    • IVF Center
    • Hospital
    • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East
    • By Product Type :
    • Consumables
    • Instruments
    • By Technology:
    • In-vitro fertilization (IVF)
    • IVF with Intracytoplasmic Sperm Injection (ICSI)
    • IVF without Intracytoplasmic Sperm Injection (ICSI)
    • Artificial Insemination-Intrauterine Insemination (AI-IUI)
    • Frozen Embryo Replacement (FER)
    • Others
    • By Procedure :
    • Fresh Donor
    • Frozen Donor
    • Fresh Nondonor
    • Frozen Nondonor
    • Embryo/Egg Banking
    • Others
    • By End User:
    • Fertility Clinics
    • IVF Center
    • Hospital
    • By Country:
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • By Product Type :
    • Consumables
    • Instruments
    • By Technology:
    • In-vitro fertilization (IVF)
    • IVF with Intracytoplasmic Sperm Injection (ICSI)
    • IVF without Intracytoplasmic Sperm Injection (ICSI)
    • Artificial Insemination-Intrauterine Insemination (AI-IUI)
    • Frozen Embryo Replacement (FER)
    • Others
    • By Procedure :
    • Fresh Donor
    • Frozen Donor
    • Fresh Nondonor
    • Frozen Nondonor
    • Embryo/Egg Banking
    • Others
    • By End User:
    • Fertility Clinics
    • IVF Center
    • Hospital
    • By Country/Region:
    • Central Africa
    • South Africa
    • North Africa
  • Company Profiles
  • Cooper Surgical Inc.*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments
  • Hamilton Thorne, Inc.
  • FUJIFILM Irvine Scientific, Inc.
  • Nidacon International AB
  • Vitrolife AB
  • EMD Serono, Inc.
  • INVO Bioscience
  • IVFtech ApS
  • Gonagen Medikal
  • Cook Medical LLC
  • CellCura ASA
  • Merck KGaA

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Technology
    • Market Snippet, By Procedure
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Novel Product Launch/Approval
    • Acquisitions and Partnerships
    • Technological Advancement
    • Regulatory Scenario
    • Reimbursement Scenario
    • Product Recalls
    • PEST Analysis
    • PORTER's Analysis
    • Epidemiology

4. Global Assistive Reproductive Technology Market, By Product Type, 2016 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017-2027
    • Segment Trends
    • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Segment Trends
    • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Segment Trends

5. Global Assistive Reproductive Technology Market, By Technology, 2016 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017-2027
    • Segment Trends
    • In-vitro fertilization (IVF)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • IVF with Intracytoplasmic Sperm Injection (ICSI)
    • IVF without Intracytoplasmic Sperm Injection (ICSI)
    • Artificial Insemination-Intrauterine Insemination (AI-IUI)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Frozen Embryo Replacement (FER)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Assistive Reproductive Technology Market, By Procedures, 2016 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017-2027
    • Segment Trends
    • Fresh Donor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Frozen Donor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Fresh Nondonor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Embryo/Egg Banking
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Assistive Reproductive Technology Market, By End User, 2016 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017-2027
    • Segment Trends
    • Fertility Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • IVF Center
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

8. Global Assistive Reproductive Technology Market, By Region, 2016 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, By Region, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
    • North America
    • Market Size and Forecast, By Product Type, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Procedure, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Region, 2016 - 2027 (US$ Mn)
    • U.S.
    • Canada
    • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Procedure, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Region, 2016 - 2027 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Procedure, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Region, 2016 - 2027 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Procedure, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Region, 2016 - 2027 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Procedure, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Region, 2016 - 2027 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
    • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Procedure, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Region, 2016 - 2027 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

9. Competitive Landscape

    • Heat Map Analysis
    • Company Profiles
    • Cooper Surgical Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Hamilton Thorne, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • FUJIFILM Irvine Scientific, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Nidacon International AB
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Vitrolife AB
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • EMD Serono, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • INVO Bioscience
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • IVFtech ApS
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Gonagen Medikal
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Cook Medical LLC.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • CellCura ASA
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Section

    • References
    • Research Methodology
    • About us and Sales Contact